133 related articles for article (PubMed ID: 38477847)
1. High antibiotic resistance rates in Helicobacter pylori strains in Turkey over 20 years: implications for gastric disease treatment.
Sarıkaya B; Çetinkaya RA; Özyiğitoğlu D; Işık SA; Kaplan M; Kırkık D; Görenek L
Eur J Gastroenterol Hepatol; 2024 May; 36(5):545-553. PubMed ID: 38477847
[TBL] [Abstract][Full Text] [Related]
2. Antibiotic Resistance of
Vu TB; Tran TNQ; Tran TQA; Vu DL; Hoang VT
Medicina (Kaunas); 2022 Dec; 59(1):. PubMed ID: 36676631
[No Abstract] [Full Text] [Related]
3. High rates of clarithromycin and levofloxacin resistance of Helicobacter pylori in patients with chronic gastritis in the south east area of Vietnam.
Dang NQH; Ha TMT; Nguyen ST; Le NDK; Nguyen TMT; Nguyen TH; Pham TTH; Tran VH
J Glob Antimicrob Resist; 2020 Sep; 22():620-624. PubMed ID: 32590188
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
Cosme A; Torrente Iranzo S; Montes Ros M; Fernández-Reyes Silvestre M; Alonso Galán H; Lizasoain J; Bujanda L
Helicobacter; 2019 Feb; 24(1):e12557. PubMed ID: 30460730
[TBL] [Abstract][Full Text] [Related]
5. Novel and Effective Therapeutic Regimens for
Hu Y; Zhu Y; Lu NH
Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
[No Abstract] [Full Text] [Related]
6. Role of proton pump inhibitors dosage and duration in Helicobacter pylori eradication treatment: Results from the European Registry on H. pylori management.
Pabón-Carrasco M; Keco-Huerga A; Castro-Fernández M; Saracino IM; Fiorini G; Vaira D; Pérez-Aísa Á; Tepes B; Jonaitis L; Voynovan I; Lucendo AJ; Lanas Á; Martínez-Domínguez SJ; Almajano EA; Rodrigo L; Vologzanina L; Brglez Jurecic N; Denkovski M; Bujanda L; Abdulkhakov RA; Huguet JM; Fernández-Salazar L; Alcaide N; Velayos B; Silkanovna Sarsenbaeva A; Zaytsev O; Ilchishina T; Barrio J; Bakulin I; Perona M; Alekseenko S; Romano M; Gravina AG; Núñez Ó; Gómez Rodríguez BJ; Ledro-Cano D; Pellicano R; Bogomolov P; Domínguez-Cajal M; Almela P; Gomez-Camarero J; Bordin DS; Gasbarrini A; Kupčinskas J; Cano-Català A; Moreira L; Nyssen OP; Mégraud F; O'Morain C; Gisbert JP;
United European Gastroenterol J; 2024 Feb; 12(1):122-138. PubMed ID: 38050339
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of bismuth for antibiotic-resistant Helicobacter pylori strains eradication: A systematic review and meta-analysis.
Han Z; Li Y; Kong Q; Liu J; Wang J; Wan M; Lin M; Lin B; Zhang W; Ding Y; Wang S; Mu Y; Duan M; Zuo X; Li YQ
Helicobacter; 2022 Dec; 27(6):e12930. PubMed ID: 36156332
[TBL] [Abstract][Full Text] [Related]
8. Antibiotic resistance profile of
Huang X; Wu B; Chen Q; Chen Y; Ji X; Zhou X; Suo B; Lin Z; Zheng X
PeerJ; 2023; 11():e15611. PubMed ID: 37456872
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of second-line regimens for
Chang YL; Tung YC; Tu YK; Yeh HZ; Yang JC; Hsu PI; Kim SE; Wu MF; Liou WS; Shiu SI
BMJ Open Gastroenterol; 2020 Sep; 7(1):. PubMed ID: 32883715
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic Resistance of
Ayaş M; Gürol Y
Microb Drug Resist; 2023 Mar; 29(3):96-103. PubMed ID: 36724307
[TBL] [Abstract][Full Text] [Related]
11. 10-Year Trends in Helicobacter pylori Eradication Rates by Sitafloxacin-Based Third-Line Rescue Therapy.
Mori H; Suzuki H; Matsuzaki J; Masaoka T; Kanai T
Digestion; 2020; 101(5):644-650. PubMed ID: 31387107
[TBL] [Abstract][Full Text] [Related]
12. A Randomized Controlled Trial Shows that both 14-Day Hybrid and Bismuth Quadruple Therapies Cure Most Patients with Helicobacter pylori Infection in Populations with Moderate Antibiotic Resistance.
Tsay FW; Wu DC; Yu HC; Kao SS; Lin KH; Cheng JS; Wang HM; Chen WC; Sun WC; Tsai KW; Hsu PI
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807915
[TBL] [Abstract][Full Text] [Related]
13. Second-line Therapy for Helicobacter Pylori Eradication: State of the Art.
Losurdo G; D'Abramo FS; Piazzolla M; Rima R; Continisio A; Pricci M; Ierardi E; Di Leo A
Mini Rev Med Chem; 2022; 22(19):2430-2437. PubMed ID: 35339174
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of Helicobacter pylori to antibiotics in Chinese patients.
Bai P; Zhou LY; Xiao XM; Luo Y; Ding Y
J Dig Dis; 2015 Aug; 16(8):464-70. PubMed ID: 26147515
[TBL] [Abstract][Full Text] [Related]
15. [Levofloxacin-based triple therapy versus bismuth-based quadruple therapy in the treatment of
Zhang M; Chen CY; Wang XT; Lyu B
Zhonghua Nei Ke Za Zhi; 2017 May; 56(5):368-374. PubMed ID: 28460509
[No Abstract] [Full Text] [Related]
16. Helicobacter pylori Multidrug Resistance Due to Misuse of Antibiotics in Iran.
Saniee P; Hosseini F; Kadkhodaei S; Siavoshi F; Khalili-Samani S
Arch Iran Med; 2018 Jul; 21(7):283-288. PubMed ID: 30041525
[TBL] [Abstract][Full Text] [Related]
17. High incidence of antibiotic resistance amongst isolates of
Garvey E; Rhead J; Suffian S; Whiley D; Mahmood F; Bakshi N; Letley D; White J; Atherton J; Winter JA; Robinson K
J Med Microbiol; 2023 Nov; 72(11):. PubMed ID: 37962209
[No Abstract] [Full Text] [Related]
18. Minimum inhibitory concentrations of commonly used antibiotics against Helicobacter Pylori: A multicenter study in South China.
Huang X; Liu Y; Lin Z; Wu B; Nong G; Chen Y; Lu Y; Ji X; Zhou X; Suo B; Chen Q; Wei J
PLoS One; 2021; 16(9):e0256225. PubMed ID: 34473713
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic Resistance of
Le LTT; Nguyen TA; Nguyen NA; Nguyen YTH; Nguyen HTB; Nguyen LT; Vi MT; Nguyen T
Healthcare (Basel); 2022 Jun; 10(6):. PubMed ID: 35742177
[TBL] [Abstract][Full Text] [Related]
20. Five-year sequential changes in secondary antibiotic resistance of Helicobacter pylori in Taiwan.
Wu IT; Chuah SK; Lee CH; Liang CM; Lu LS; Kuo YH; Yen YH; Hu ML; Chou YP; Yang SC; Kuo CM; Kuo CH; Chien CC; Chiang YS; Chiou SS; Hu TH; Tai WC
World J Gastroenterol; 2015 Oct; 21(37):10669-74. PubMed ID: 26457027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
